MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...
Abstract: The use of fossil energy which is always increasing from year to year makes it seem as if the world cannot be separated from these energy source. Therefore, it is necessary to find new ...
Abstract: This paper conducts a current control design method for three-phase voltage source inverter (VSI) grid-tied with LCL filter in the synchronous reference frame (SRF), based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback